HEARTWOOD PHARMA
Dead / Cancelled — Cancelled — Section 8 (as of 19 Oct 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88294451
- Registration number
- 6025243
- Mark type
- Word mark
- Filed
- 08 Feb 2019
- Published for opposition
- 18 Jun 2019
- Registered
- 31 Mar 2020
- Attorney of record
- Seth A. Rappaport
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of schizophrenia
Owner
- HLS Therapeutics (USA), Inc., Rosemont, PA, US
- HLS Therapeutics (USA), Inc., Rosemont, PA, US
- HLS Therapeutics (USA), Inc., Rosemont, PA, US
Prosecution history
- 19 Oct 2026 — CANCELLED SEC. 8 (6-YR)
- 10 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 31 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 26 Feb 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Feb 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Feb 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Jan 2020 — USE AMENDMENT FILED
- 11 Feb 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jan 2020 — TEAS STATEMENT OF USE RECEIVED
- 13 Aug 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2019 — PUBLISHED FOR OPPOSITION
- 29 May 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 May 2019 — ASSIGNED TO LIE